NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Joanna Ratajczak et al. · Nature Communications · 2016
Evidence type: Cellular and structural studyInterpretive weight: Mechanistic contextResearch area: NMN uptake and metabolism mechanisms
DesignCellular and mouse mechanistic metabolism study using genetic disruption of nicotinamide riboside kinase pathways
PopulationMammalian cell systems and mouse experiments
SampleMultiple cellular and animal experiments; see publication
InterventionNMN and nicotinamide riboside exposure with manipulation of NRK1-related metabolism
EndpointsNAD+ synthesis from NMN and NR; NRK1 dependence; Extracellular precursor conversion; Tissue and cellular precursor metabolism
What the publication reported
This mechanistic study investigated how mammalian cells use NMN and nicotinamide riboside to make NAD+.
The experiments showed that NRK1 is important for the metabolism of both precursors and supported a pathway in which extracellular NMN can be dephosphorylated to NR before cellular uptake in the studied systems.
The results are central to debates about how administered NMN reaches cells, but they are mechanistic cell and animal findings rather than direct human absorption data.
Key findings
NRK1 was required for efficient NAD+ synthesis from nicotinamide riboside.
NMN utilization was also strongly dependent on NRK1-related metabolism in the tested systems.
The data supported extracellular conversion of NMN to NR before uptake in key experimental contexts.
Precursor handling varied by biological context.
What it cannot establish
Primarily cell and mouse mechanistic evidence.
Metabolic routes may vary among tissues and species.
The experiments do not establish the dominant route of oral NMN handling in humans.
Mechanistic precursor conversion does not determine clinical efficacy.
HealthspanX claim boundary: This study does not determine human oral NMN bioavailability, clinical efficacy, or the exact dominant uptake pathway in people.
